Previous close | 32.00 |
Open | 31.80 |
Bid | 31.80 x 0 |
Ask | 32.80 x 0 |
Day's range | 31.80 - 32.00 |
52-week range | 29.60 - 35.60 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering Strategic partnership provides a seamless one-stop-shop for biopharmaceutical development and manufacturing for large pharma, mid-size biotech’s and startup developers.The AGC Biologics & BioConnection collaboration offers new option for companies evaluating the potential impact of U.S. BIOSECURE Act. SEATTLE & OSS – May 22, 2024AGC Biologics, a
TOKYO, May 13, 2024--AGC Glass Asia’s Mirox MNGE, a low lead mirror, is awarded with Cradle to Cradle Certified® at the Bronze level based on version 3.1.
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.